| Literature DB >> 29888041 |
Cindy Chen1, Regina T Wulff2, Evan T Sholle1, Gail J Roboz2, David A Kraemer1, Thomas R Campion1,3,4,5.
Abstract
To enable clinical and translational research, academic medical centers increasingly implement biospecimen information management systems. At our institution, one laboratory successfully implemented a multi-system solution that enabled collection and reporting of specimen- and aliquot-level data. The objective of this study was to assess the solution against the laboratory's requirements and with respect to support of best practices for biospecimen information management systems defined by the International Society for Biological and Environmental Repositories (ISBER). The solution supported the laboratory's reporting needs and 90% (n=26) of ISBER best practices. To the best of our knowledge, this is among the first studies to demonstrate the generalizability of a biospecimen informatics approach. Findings suggest that development and evaluation of biospecimen informatics approaches can potentially improve through closer collaboration of informatics and biorepository professional societies.Entities:
Year: 2018 PMID: 29888041 PMCID: PMC5961803
Source DB: PubMed Journal: AMIA Jt Summits Transl Sci Proc
FreezerPro standard fields and user-defined fields.
| Standard Fields | User-Defined Fields |
|---|---|
| Name | Legacy ID |
| Description | Process method |
| Freezer location | Process start time |
| Sample source | Storage media used |
| Sample group | Total viable cells |
| Sample type | Method of sample destruction |
| Sample owner | Nucleic acid concentration by qubit |
| Percent viability | |
| Final destination | |
| Percent purity by flow |
Reporting requirements specified by Leukemia Program personnel
| User role | Reporting requirement |
|---|---|
| Clinician | For Patient Y: How many (parent) specimens were submitted to the biobank? How many bone marrow PLASMA sample aliquots were submitted by each collection protocol? List the aliquots and their locations. |
| Clinician | For Diagnosis X: How many (parent) specimens were submitted to the biobank? How many bone marrow PLASMA sample aliquots were submitted by each collection protocol? List the aliquots and their locations. |
| Clinician | For Protocol Z: How many (parent) specimens were submitted to the biobank? How many bone marrow PLASMA sample aliquots are stored with LEUKEMIA STUDY IDs? With TRANSPLANT STUDY IDs? List the aliquots and their locations. |
| Researcher | How many biobanked samples fit the following description: 50-70 year old female (age frozen in time), CD15+ WBC Cell Pellet stored, aliquot >95% Pure by flow (regardless of diagnosis)? List the aliquots and their locations. |
| Laboratory personnel | How many biobanked samples are from >90 year old females? (age is frozen in time)? How many by sample type (PLASMA, MNC CELL PELLET, MNC CRYOPRESERVED, etc.)? List the aliquots and their location. |
| Laboratory personnel | What is the total average turn-around-time from specimen collection to specimen storage? By collection protocol? By process method? By technician? |
| Laboratory personnel | From today’s date, how many MNC CRYOPRESERVED aliquots have been stored for >10 years? What are the “same day” CBC characteristics for those aliquots? List the aliquots and their location. |
| Any | A single report of all available data in FreezerPro given 20+ unique Specimen ID numbers? ( |
| Any | Identify all peripheral blood plasmas less than 6 hours old |
Evaluation of FreezerCap-SQL with respect to ISBER best practices reproduced from (16).
| ISBER Information System Evaluation Checklist-Best Practices | FreezerCap-SQL |
|---|---|
| System provides ability to maintain controlled vocabularies (ontologies) to enforce data standardization and control. | Yes |
| System provides users with intuitive on-demand access to data and the ability to represent the data (for view, file export or print) in a variety of formats without knowledge of proprietary code. | Yes |
| System is capable of maintaining user profiles and credentialing users for different levels of access and functionality. | Yes |
| System provides audit trail that minimally tracks userid, date, and content of change at the field level | Yes |
| Data elements pertaining to each subject are sufficiently extensive or extensible (e.g. the ability to maintain demographic attributes including race, ethnicity, date of birth, gender)? | Yes |
| System provides ability to track and manage events associated with a particular subject and date (e.g. visit, donation, examination, etc.) | No |
| Provides ability to associate a subject with a study | Yes |
| Provides ability to assign system-generated, unique subject identifier | Yes |
| Provides ability to manage subject de-identification. | Yes |
| System provides ability to generate/assign a unique accession to each sample. | Yes |
| System provides ability to define an unlimited number of samples: whole-blood, tissue, cellular lysates, DNA, RNA, proteins, etc. | Yes |
| System provides ability to assign sample component with physical location | Yes |
| System provides ability to associate the sample and component to the participant. | Yes |
| System provides ability to annotate sample with sample attributes, like method of specimen preparation and environmental conditions under which specimen is stored: (e.g. type of sample, volume, container size, description, date drawn, source of sample, person storing, temperature.) | Yes |
| System provides ability to a user with special permissions to define hierarchical storage configurations. | Yes |
| System provides ability to track specimens with barcoded IDs printed on labels | Yes |
| Provides ability to query/search inventory of specimen and specimen components. | Yes |
| System maintains sample genealogy on aliquots, derivative, and pooled samples (e.g. DNA derived from PBMC derived from whole blood) | No |
| System provides logistics management and chain-of-custody tracking (e.g. shipping and receiving) | Yes |
| System provides ability to configure rules or restrictions to manage access to specimen information. | Yes |
| System provides mechanism for maintaining specimen lifecycle and disposition (e.g., system tracks amount used and decrements from available amount). | Yes |
| System provides ability to create and maintain complex queries/searches using associated subject attributes or experiment data as search criteria | Yes |
| Provides the user with a defined process for creating queries/searches on data in the system. | Yes |
| Provides ability to create and maintain reports as standard reports that can be selected by a user from a list | Yes |
| Provide the user with the ability to define ad hoc queries/searches and custom reports in common terms, without requiring knowledge of proprietary code. | No |
| Provide the user with the ability to save queries/searches for future reuse. | Yes |
| System provides ability to export data in delimited formats: .csv, or .xls and XML | Yes |
| System has an integrated database. Describe the database management system (DBMS) that is most commonly used with the System. | Yes |
| System is capable of interfacing with third party data sources, applications and services. | Yes |